Company: FCRX
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001133228-25-003192
Chunk: 4

Company: Crescent Capital BDC, Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 4
---
 be able to attend the Annual
Meeting online and submit your questions during the meeting by visiting www.virtualshareholdermeeting.com/CCAP2025 and entering your 16-digit
control number included in your Notice of Internet Availability, on your proxy card or on the instructions that accompanied your proxy
materials. If you lose your 16-digit control number, you may join the Annual Meeting as a “Guest” but you will not be able
to vote, or ask questions. The Corporation is a closed-end management investment company that has elected to be treated as a business
development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Crescent Cap
Advisors, LLC, a Delaware limited liability company (the “Advisor”), serves as the investment adviser to the Corporation.
CCAP Administration LLC, a Delaware limited liability company (the “Administrator”), serves as the administrator to the Corporation.
The principal executive offices of each of the Corporation, the Advisor, and the Administrator are located at 11100 Santa Monica Blvd.,
Suite 2000, Los Angeles, California 90025.

This
Proxy Statement and the accompanying Notice and form of proxy are being provided to stockholders on or about April 1, 2025. The Board
has fixed the close of business on March 19, 2025 as the record date (the “Record Date”) for the determination of stockholders
entitled to receive notice of, and to vote at, the Annual Meeting. As of the Record Date, 37,061,547 shares of the Corporation’s
common stock, par value $0.001 per share (the “Common Stock”) were issued and outstanding, and the Corporation had not issued
any shares of preferred stock. Stockholders of the Corporation are entitled to cast one vote for each share held and fractional votes
for each fractional share held.

If
the form of proxy is properly executed and returned in time to be voted at the Annual Meeting, the shares covered thereby will be voted
at the Annual Meeting in accordance with the instructions marked thereon. All properly executed proxies received by the Board that do
not specify how shares should be voted will be voted “FOR” the election of each of Kathleen S. Briscoe and George G. Strong,
Jr. (the “Class I Director Nominees”) (“Proposal 1”); “FOR” the ratification of the selection
of Ernst & Young LLP (“E&Y”) as the independent